In the company’s annual shareholders meeting, Chairman and CEO Francisco Milleri detailed how Essilux is progressively shifting from a hardware-oriented to a service-oriented business centered on AI and medtech. More acquisitions in the AI, chips design and eye surgery sectors are into the group’s deals pipe for 2025 and 2026. The company is taking a cautious approach to US tariffs supply chain adjustments.
Buying a membership today will give you:
To continue reading this article register now.